Back to search

Article

Post-hoc biomarker analyses of T4a/T4b gastric cancer from patients recruited into SAMIT, a phase III randomized controlled trial

2021-04-15

Abstract excerpt

Biomarkers for selecting gastric cancer (GC) patients likely to benefit from sequential paclitaxel treatment followed by fluorinated-pyrimidine-based adjuvant chemotherapy were searched for using samples of patients recruited into SAMIT, a phase III randomized controlled trial. Total RNA was extracted from 556 GC patients and the expression of 105 genes were quantified using real-time PCR. Genes predicting positiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c3e9514-3baa-5792-9106-d94291a61926
DOI
10.21203/rs.3.rs-393330/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Post-hoc biomarker analyses of T4a/T4b gastric cancer from patients recruited into SAMIT, a phase III randomized controlled trialDOI 10.21203/rs.3.rs-393330/v1
Select a neighboring publication to make it the new centre.